Epidemiological and clinical risk factors related to severe COVID-19 in Iran: a multi-center study

Iran was one of the first countries to be affected by COVID-19. Identifying factors associated with the severity of COVID-19 is effective in disease management. This study investigated the epidemiological and clinical features and factors related to the severity of COVID-19 in one of the less privil...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC infectious diseases 2022-02, Vol.22 (1), p.184-184, Article 184
Hauptverfasser: Hashemi-Shahri, Seyed Mohammad, Tabatabaei, Seyed Mohammad Nasiraldin, Ansari-Moghaddam, Alireza, Mohammadi, Mahdi, Okati-Aliabad, Hassan, Tabatabaei, Seyed Mehdi, Ansari, Hossein, Abbasi, Mohammadhadi, Sheikhzadeh, Khodadad, Baygi, Mehdi Zanganeh, Sartipi, Majid, Sanei-Sistani, Sharareh, Khorashad, Ali Reza Salimi, Ansari-Moghadam, Fatemeh, Torab, Neda, Khalili, Tahereh, Miri-Aliabad, Ghasem
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Iran was one of the first countries to be affected by COVID-19. Identifying factors associated with the severity of COVID-19 is effective in disease management. This study investigated the epidemiological and clinical features and factors related to the severity of COVID-19 in one of the less privileged areas in Iran. In a multi-center study, all patients admitted to Zahedan University of Medical Sciences hospitals in southeastern Iran were investigated from February 29 to April 31, 2020. Demographic, epidemiological, and clinical data of patients were extracted from medical records. Bivariate and multivariate logistic regression models were used to explore the risk factors associated with the severity of COVID-19. Among the 413 patients, 55.5% were male, and 145 (35.10%) were in a severe condition at admission time. Multivariate analysis showed that the adjusted odds of the disease severity increased in patients with older age (OR 2.27; 95% CI 1.41-3.65), substance abuse (OR 2.49; 95% CI 1.14-5.43), having one underlying disease (OR 1.52; 95% CI 0.90-2.55), having two underlying disease (OR 2.31; 95% CI 1.19-4.50), and having three or more underlying disease (OR 2.60; 95% CI 1.19-5.66). COVID-19 was more severe in older patients, patients with a history of substance abuse, and patients with the underlying disease. Understanding the factors affecting the disease severity can help the clinical management of COVID-19, especially in less privileged areas where fewer resources are available.
ISSN:1471-2334
1471-2334
DOI:10.1186/s12879-022-07165-0